Latest Bayer AG Stories
Claritin, the #1 Selling Non-Drowsy Allergy Brand, is the Proud Sponsor of Spring NEW YORK, March 20, 2015 /PRNewswire/ -- Bayer HealthCare, the makers of Claritin(®), the #1 selling non-drowsy
The plastic additives market is projected to register a CAGR of 5.0% between 2014 and 2019 to reach $45.5 billion by 2019.
10th Annual Ag Issues Forum Brings Together Agriculture, Food, Consumer Leaders PHOENIX, Feb. 24, 2015 /PRNewswire/ -- Nourishing the world tomorrow requires innovation today.
WHIPPANY, N.J., Feb. 9, 2015 /PRNewswire/ -- More than 700,000 people suffer heart attacks and 795,000 people have a stroke each year in the United States.
Three UCSF researchers are partnering with Bayer HealthCare in this unique academic-industry collaboration SAN FRANCISCO, Jan.
Multidistrict Litigation For Xarelto Bleeding Lawsuits That Allege Patients Experienced Uncontrollable Bleeding And Other Complications After Taking The Prescription Blood Thinner Has Been Established
A Request To Centralize Xarelto Lawsuits Alleging Xarelto Users Experience Uncontrolled Bleeding Due To Taking The Blood Thinner Is Under Consideration By the U.S.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
Xarelto Page Launched to Monitor Lawsuits Being Filed on Behalf of Patients Who Allege the Blood Thinner Causes Severe Internal Bleeding and Uncontrollable Bleeding New
DUBLIN, November 4, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dk8mkw/micro_market) has announced the addition of the "Micro
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.